Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial-Reference-Cited by-同舟云学术

Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial

Published:2021-04-14 Issue:8 Volume:23 Page:1754-1764
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Weng Jianping¹^ORCID,Zeng Longyi²,Zhang Yuwei³,Qu Shen⁴,Wang Xueying⁵,Li Ping⁶,Fu Liujun⁷,Ma Boqing⁸,Ye Shandong¹,Sun Jiao⁹,Lu Weiping¹⁰,Liu Zhiwen¹¹,Chen Daoxiong¹²,Cheng Zhifeng¹³,Liu Haiyan¹⁴,Zhang Tao¹⁴,Zou Jianjun¹⁴

Affiliation:

1. Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China Hefei Anhui China

2. Third Affiliated Hospital of Sun Yat‐sen University Guangzhou China

3. Huaxi Hospital of Sichuan University Chengdu China

4. Shanghai 10th People's Hospital Shanghai China

5. Jinzhou Central Hospital Jinzhou China

6. Yuncheng Central Hospital Taiyuan China

7. First Affiliated Hospital of Henan University of Science and Technology Luoyang China

8. Hebei General Hospital Shijiazhuang China

9. Huadong Hospital Affiliated to Fudan University Shanghai China

10. First Affiliated Huai'an Hospital of Nanjing Medical University Huai'an China

11. Shanghai Xuhui District Central Hospital Shanghai China

12. Hainan General Hospital Haikou China

13. Fourth Affiliated Hospital of Harbin Medical University Harbin China